Amlodipine mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine Mechanism of Action: Calcium Channel Blockade and Beyond
L-Type Calcium Channel Blockade in Blood Vessels
Amlodipine is primarily known as a third-generation calcium channel blocker, specifically a 1,4-dihydropyridine derivative. Its main mechanism is the inhibition of voltage-dependent L-type calcium channels in vascular smooth muscle, which leads to vasodilation and a reduction in blood pressure. This action is responsible for its effectiveness in treating hypertension and coronary artery diseases, and it is characterized by a prolonged duration of effect due to its optimal lipophilicity and slow binding kinetics .
Nitric Oxide Release and Vascular Effects
Unlike some other calcium channel blockers, amlodipine has been shown to stimulate the release of nitric oxide (NO) from blood vessels. This NO release contributes to vasodilation and may provide additional cardiovascular protection. The effect is dose-dependent and has been observed in both coronary microvessels and large arteries, setting amlodipine apart from other drugs in its class such as nifedipine and diltiazem 1479. The NO-mediated effects are thought to involve stimulation of kinin receptors and local kinin formation .
Anti-Inflammatory and Antioxidant Properties
Amlodipine exhibits significant anti-inflammatory actions. It reduces the expression of inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which are implicated in the progression of heart failure and vascular inflammation 2358. In experimental models, amlodipine also decreases the expression of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2, further limiting vascular inflammation and the development of arteriosclerosis 58.
Additionally, amlodipine acts as a potent antioxidant. It inhibits lipid peroxidation and reduces oxidative stress in endothelial cells, which helps to improve endothelial function, especially in conditions like diabetes where oxidative damage is prominent. These antioxidant effects are attributed to its unique membrane interactions and are independent of its calcium channel blocking activity 569.
Modulation of Cellular Signaling Pathways
Amlodipine influences several cellular signaling pathways. It activates the PI3K/Akt pathway, which is involved in cell survival and anti-inflammatory responses, and inhibits the activation of pro-inflammatory pathways such as p38 MAPK and NF-κB. These actions contribute to its ability to suppress the production of inflammatory mediators and protect against cardiac dysfunction, particularly in settings of sepsis or chronic inflammation 25.
Additional Mechanisms: GABA Receptor Interaction
Some evidence suggests that certain amlodipine derivatives may interact with GABA A receptors in the brain, contributing to vasodilatory effects in cerebral ischemia. However, this mechanism appears to be more pronounced with specific amlodipine formulations and is less significant compared to its primary vascular actions .
Conclusion
Amlodipine’s mechanism of action extends beyond simple L-type calcium channel blockade. It also promotes nitric oxide release, exhibits anti-inflammatory and antioxidant effects, and modulates key cellular signaling pathways. These pleiotropic actions contribute to its cardiovascular protective effects and may explain its benefits in conditions such as hypertension, atherosclerosis, and heart failure 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic
Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway.
Amlodipine can protect against cardiac dysfunction in sepsis by inhibiting TNF-alpha production and reducing iNOS levels, partly through the PI3K/Akt signaling pathway.
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.
Amlodipine, a calcium channel blocker, releases nitric oxide from blood vessels, potentially benefiting heart failure patients by reducing mortality.
Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL.
Amlodipine may improve endothelial dysfunction in diabetes through anti-oxidant and anti-inflammatory mechanisms.
Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.
Amlodipine releases nitric oxide from canine coronary microvessels, an unexpected mechanism of action for a calcium channel-blocking agent.
ГАМК А -рецепторные механизмы противоишемического цереброваскулярного эффекта S-амлодипина никотината
S-amlodipine nicotinate enhances blood supply to damaged brains more effectively than amlodipine besylate, with a GABA-ergic mechanism of action.
DOI